EVERSANA is proud to sponsor the virtual 2021 Pharma/Biotech GTN Summit from November 17-19, 2021.
The GTN Summit is the foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for life science companies. Connect with EVERSANA and other industry leaders to discuss pharma and biotech best practices for GTN management, effective forecasts, enhanced visibility, profitability and control. Register here!
需要应用临床路径，并通过制定质量指标基准和适当使用标准来执行这些路径，以防止出现鼓励过度使用和使用不足的不正当经济激励措施。.展望未来，付款人和综合交付网络在制定临床路径时，越是努力评估和纳入使用标准，我们的系统就会越好。
下载最新白皮书 收入管理专家罗伯特-布兰克（Robert Blank）的文章，了解更多信息：
- 支付方政策和市场动态可能导致医疗保健治疗的过度使用或使用不足。
- 通过医疗保险和医疗补助服务中心的新政策努力和临床路径应用，有机会减轻以前政策的意外后果。
- 如何降低潜在风险，同时通过评估拟议的承包战略，确认成功所需的业务能力。
At EVERSANA, we help you reduce revenue leakage, implement innovative contracting strategies and execute improved business processes that drive bottom-line impact. We leverage our deep expertise in the operational, technology and government compliance issues facing the industry to bring solutions ranging from business process outsourcing services, technology and data assets, and advisory services.